Dr. Ram Kiran Parvataneni, MD

Dr. Parvataneni practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Parvataneni's NPI, 1669414744, was assigned on June 12, 2006. Dr. Parvataneni graduated from University of the West Indies Faculty of Medical Sciences in 1996. Dr. Parvataneni holds California license A82739.

Dr. Parvataneni's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Parvataneni's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Parvataneni is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health Westwood OBGYN. Dmand AI also links Dr. Parvataneni to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parvataneni practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecology is Dr. Parvataneni's primary specialty in the NPI Registry, under taxonomy code 207VG0400X. Dr. Parvataneni is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dr. Parvataneni is licensed in California.

Dmand AI lists menopause and vaginal infection among the conditions Dr. Parvataneni treats.

CMS data shows 107 Medicare services from Dr. Parvataneni across 4 procedure codes in 2024, for 84 Medicare patients. Medicare paid $6,239 for them. Every service was in an office.

CMS counts 84 Medicare patients who saw Dr. Parvataneni in 2024. The largest group is 65 to 74, with 45 patients. 69% of them have high cholesterol, and 61% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Parvataneni's median patient age at 43, with 99% women.

In 2024, Dr. Parvataneni wrote 115 Medicare Part D claims for 57 patients. 72% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $7,162 in total drug cost. In 2023, CMS named 64 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Parvataneni for performance year 2024, reported as part of a group. Dr. Parvataneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parvataneni as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Parvataneni in 2024. Dr. Parvataneni's most frequent co-authors are Antoinette Allen, MD, Kimberly Anne Kho, MD and Naghmeh S. Salamat-Saberi, MD.

Dmand AI links Dr. Parvataneni to 1 clinical trial.

CMS Open Payments shows 4 general payments to Dr. Parvataneni from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Applied Medical Resources Corporation paid the most, $136.

Dmand AI lists 2 awards for Dr. Parvataneni, most recently CMS Stage 1 EHR in 2013.

Dr. Parvataneni graduated from University of the West Indies Faculty of Medical Sciences in 1996. Dr. Parvataneni is a member of American College of Obstetricians and Gynecologists.

Dr. Parvataneni is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.